These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 18686091

  • 1. Evaluation of mucilage of Hibiscus rosasinensis Linn as rate controlling matrix for sustained release of diclofenac.
    Jani GK, Shah DP.
    Drug Dev Ind Pharm; 2008 Aug; 34(8):807-16. PubMed ID: 18686091
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of Mimosa pudica seed mucilage as sustained-release excipient.
    Singh K, Kumar A, Langyan N, Ahuja M.
    AAPS PharmSciTech; 2009 Aug; 10(4):1121-7. PubMed ID: 19763837
    [Abstract] [Full Text] [Related]

  • 3. Extraction characterization and evaluation of selected mucilage as pharmaceutical excipient.
    Malviya R.
    Polim Med; 2011 Aug; 41(3):39-44. PubMed ID: 22046826
    [Abstract] [Full Text] [Related]

  • 4. Formulation and evaluation of Ficus glomerata mucilage sustained release matrix tablets of gliclazide.
    Kumar CS, Reddy-Budideti KK, Battula SP, Ayyavala CS.
    Pak J Pharm Sci; 2011 Jul; 24(3):399. PubMed ID: 21715275
    [Abstract] [Full Text] [Related]

  • 5. Development and evaluation of Ketoprofen sustained release matrix tablet using Hibiscus rosa-sinensis leaves mucilage.
    Kaleemullah M, Jiyauddin K, Thiban E, Rasha S, Al-Dhalli S, Budiasih S, Gamal OE, Fadli A, Eddy Y.
    Saudi Pharm J; 2017 Jul; 25(5):770-779. PubMed ID: 28725150
    [Abstract] [Full Text] [Related]

  • 6. Design and evaluation of matrix-based controlled release tablets of diclofenac sodium and chondroitin sulphate.
    Avachat A, Kotwal V.
    AAPS PharmSciTech; 2007 Oct 19; 8(4):E88. PubMed ID: 18181548
    [Abstract] [Full Text] [Related]

  • 7. Development of an osmotic pump system for controlled delivery of diclofenac sodium.
    Emara LH, Taha NF, Badr RM, Mursi NM.
    Drug Discov Ther; 2012 Oct 19; 6(5):269-77. PubMed ID: 23229148
    [Abstract] [Full Text] [Related]

  • 8. Optimization of drug release from compressed multi unit particle system (MUPS) using generalized regression neural network (GRNN).
    Ivic B, Ibric S, Betz G, Zorica D.
    Arch Pharm Res; 2010 Jan 19; 33(1):103-13. PubMed ID: 20191351
    [Abstract] [Full Text] [Related]

  • 9. Controlled-release cellulose esters matrices for water-soluble diclofenac sodium: compression and dissolution studies.
    Obeidat WM, Alzoubi NM.
    Pharmazie; 2014 Feb 19; 69(2):96-103. PubMed ID: 24640597
    [Abstract] [Full Text] [Related]

  • 10. Melt extrusion bioadhesive delivery of diclofenac sodium granules using theobroma oil.
    Attama AA, Adikwu MU.
    Boll Chim Farm; 2004 May 19; 143(4):174-7. PubMed ID: 15255341
    [Abstract] [Full Text] [Related]

  • 11. STUDYING THE IMPACT OF FORMULATION AND PROCESSING PARAMETERS ON THE RELEASE CHARACTERISTICS FROM HYDROXYPROPYL METHYLCELLULOSE MATRIX TABLETS OF DICLOFENAC.
    Elzayat EM, Abdel-Rahman AA, Ahmed SM, Alanazi FK, Habib WA, Sakr A.
    Acta Pol Pharm; 2016 May 19; 73(2):439-52. PubMed ID: 27180437
    [Abstract] [Full Text] [Related]

  • 12. Preparation, in vitro, preclinical and clinical evaluations of once daily sustained release tablets of aceclofenac.
    Mutalik S, Naha A, Usha AN, Ranjith AK, Musmade P, Manoj K, Anju P, Prasanna S.
    Arch Pharm Res; 2007 Feb 19; 30(2):222-34. PubMed ID: 17366745
    [Abstract] [Full Text] [Related]

  • 13. Formulation and in vivo evaluation of diclofenac sodium sustained release matrix tablet: effect of compression force.
    Taha EI, Shazly GA, Harisa GI, Barakat NS, Al-Enazi FK, Elbagory IM.
    Pak J Pharm Sci; 2015 Mar 19; 28(2):573-9. PubMed ID: 25730790
    [Abstract] [Full Text] [Related]

  • 14. Influence of excipients, drugs, and osmotic agent in the inner core on the time-controlled disintegration of compression-coated ethylcellulose tablets.
    Lin SY, Lin KH, Li MJ.
    J Pharm Sci; 2002 Sep 19; 91(9):2040-6. PubMed ID: 12210050
    [Abstract] [Full Text] [Related]

  • 15. Hydroxyethyl Pachyman as a novel excipient for sustained-release matrix tablets.
    Zhou X, Wang P, Wang J, Liu Z, Hong X, Xiao Y, Liu P, Hu X.
    Carbohydr Polym; 2016 Dec 10; 154():1-7. PubMed ID: 27577889
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of Plantago major L. seed mucilage as a rate controlling matrix for sustained release of propranolol hydrochloride.
    Saeedi M, Morteza-Semnani K, Sagheb-Doust M.
    Acta Pharm; 2013 Mar 10; 63(1):99-114. PubMed ID: 23482316
    [Abstract] [Full Text] [Related]

  • 17. Soluble filler as a dissolution profile modulator for slightly soluble drugs in matrix tablets.
    Dvorácková K, Rabisková M, Masteiková R, Muselík J, Krejcová K.
    Drug Dev Ind Pharm; 2009 Aug 10; 35(8):930-40. PubMed ID: 19274510
    [Abstract] [Full Text] [Related]

  • 18. Modulating drug release profiles by lipid semi solid matrix formulations for BCS class II drug--an in vitro and an in vivo study.
    M K, Sistla R, Shastri NR.
    Drug Deliv; 2015 May 10; 22(3):418-26. PubMed ID: 24471823
    [Abstract] [Full Text] [Related]

  • 19. Preparation and in vitro evaluation of sustained release tablet formulations of diclofenac sodium.
    Savaşer A, Ozkan Y, Işimer A.
    Farmaco; 2005 Feb 10; 60(2):171-7. PubMed ID: 15752476
    [Abstract] [Full Text] [Related]

  • 20. Dissolution parameters for sodium diclofenac-containing hypromellose matrix tablet.
    Mourão SC, da Silva C, Bresolin TM, Serra CH, Porta V.
    Int J Pharm; 2010 Feb 15; 386(1-2):201-7. PubMed ID: 19941944
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.